256 related articles for article (PubMed ID: 18539355)
21. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles.
Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y
Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306
[TBL] [Abstract][Full Text] [Related]
22. In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments.
Bae Y; Nishiyama N; Kataoka K
Bioconjug Chem; 2007; 18(4):1131-9. PubMed ID: 17488066
[TBL] [Abstract][Full Text] [Related]
23. Multifunctional polymeric micelles for enhanced intracellular delivery of doxorubicin to metastatic cancer cells.
Xiong XB; Mahmud A; Uludağ H; Lavasanifar A
Pharm Res; 2008 Nov; 25(11):2555-66. PubMed ID: 18636321
[TBL] [Abstract][Full Text] [Related]
24. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
25. A smart flower-like polymeric micelle for pH-triggered anticancer drug release.
Oh KT; Oh YT; Oh NM; Kim K; Lee DH; Lee ES
Int J Pharm; 2009 Jun; 375(1-2):163-9. PubMed ID: 19481702
[TBL] [Abstract][Full Text] [Related]
26. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G
J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819
[TBL] [Abstract][Full Text] [Related]
27. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation.
Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J
Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356
[TBL] [Abstract][Full Text] [Related]
28. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
Xiong XB; Ma Z; Lai R; Lavasanifar A
Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
[TBL] [Abstract][Full Text] [Related]
29. Tumor targeting by pH-sensitive, biodegradable, cross-linked N-(2-hydroxypropyl) methacrylamide copolymer micelles.
Zhou Z; Li L; Yang Y; Xu X; Huang Y
Biomaterials; 2014 Aug; 35(24):6622-35. PubMed ID: 24814427
[TBL] [Abstract][Full Text] [Related]
30. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles.
Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J
Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793
[TBL] [Abstract][Full Text] [Related]
31. Development of novel polymeric micellar drug conjugates and nano-containers with hydrolyzable core structure for doxorubicin delivery.
Mahmud A; Xiong XB; Lavasanifar A
Eur J Pharm Biopharm; 2008 Aug; 69(3):923-34. PubMed ID: 18430550
[TBL] [Abstract][Full Text] [Related]
32. Transferrin receptor-targeted pH-sensitive micellar system for diminution of drug resistance and targetable delivery in multidrug-resistant breast cancer.
Gao W; Ye G; Duan X; Yang X; Yang VC
Int J Nanomedicine; 2017; 12():1047-1064. PubMed ID: 28223798
[TBL] [Abstract][Full Text] [Related]
33. Poly(styrene-alt-maleic anhydride)-based diblock copolymer micelles exhibit versatile hydrophobic drug loading, drug-dependent release, and internalization by multidrug resistant ovarian cancer cells.
Baranello MP; Bauer L; Benoit DS
Biomacromolecules; 2014 Jul; 15(7):2629-41. PubMed ID: 24955779
[TBL] [Abstract][Full Text] [Related]
34. Targeted doxorubicin nanotherapy strongly suppressing growth of multidrug resistant tumor in mice.
Nguyen DH; Lee JS; Bae JW; Choi JH; Lee Y; Son JY; Park KD
Int J Pharm; 2015 Nov; 495(1):329-335. PubMed ID: 26325307
[TBL] [Abstract][Full Text] [Related]
35. A biodegradable pH-sensitive micelle system for targeting acidic solid tumors.
Sethuraman VA; Lee MC; Bae YH
Pharm Res; 2008 Mar; 25(3):657-66. PubMed ID: 17999164
[TBL] [Abstract][Full Text] [Related]
36. Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant.
Sharma AK; Zhang L; Li S; Kelly DL; Alakhov VY; Batrakova EV; Kabanov AV
J Control Release; 2008 Nov; 131(3):220-7. PubMed ID: 18722489
[TBL] [Abstract][Full Text] [Related]
37. pH-sensitive properties of surface charge-switched multifunctional polymeric micelle.
Oh KT; Kim D; You HH; Ahn YS; Lee ES
Int J Pharm; 2009 Jul; 376(1-2):134-40. PubMed ID: 19394414
[TBL] [Abstract][Full Text] [Related]
38. TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors.
Sethuraman VA; Bae YH
J Control Release; 2007 Apr; 118(2):216-24. PubMed ID: 17239466
[TBL] [Abstract][Full Text] [Related]
39. Bioactive lipids-based pH sensitive micelles for co-delivery of doxorubicin and ceramide to overcome multidrug resistance in leukemia.
Wang Y; Ding Y; Liu Z; Liu X; Chen L; Yan W
Pharm Res; 2013 Nov; 30(11):2902-16. PubMed ID: 23793993
[TBL] [Abstract][Full Text] [Related]
40. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
Zhang J; Zhao X; Chen Q; Yin X; Xin X; Li K; Qiao M; Hu H; Chen D; Zhao X
Acta Biomater; 2017 Mar; 50():381-395. PubMed ID: 27956367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
